Unknown

Dataset Information

0

The clinical value of Huangqi injection in the treatment of leucopenia: a meta-analysis of clinical controlled trials.


ABSTRACT:

Background

Huangqi injection is derived from Astragalus membranaceus root. In China, recent reports of Huangqi injection for the treatment of leucopenia have emerged. However, a systematic review of these reports has not been performed. Thus, we conducted a meta-analysis of clinical controlled trials to assess the clinical value of Huangqi injection in the treatment of leucopenia.

Methods

We searched the Chinese Biomedical Literature Database (CBM), Wanfang Database, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), as well as PubMed and EMBASE to collect the data about trials of Huangqi injection for treating leucopenia. A meta-analysis was performed using RevMan 5.2 software.

Results

A total of 13 studies involving 841 patients were included in this study. The overall study quality was lower according to the Jadad scale. The meta-analysis showed that experimentally treated patients experienced greater therapeutic efficacy and lower white blood cell counts than control groups treated with Western medicine (P < 0.05). No publication bias was evident, according to Egger's test.

Conclusions

The validity of this meta-analysis was limited by the overall poor quality of the included studies. Huangqi injection may have potential clinical value in the treatment of leucopenia, but confirmation with rigorously well-designed multi-center trials is needed.

SUBMITTER: Zhang C 

PROVIDER: S-EPMC3861487 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

The clinical value of Huangqi injection in the treatment of leucopenia: a meta-analysis of clinical controlled trials.

Zhang Changsong C   Zhu Changtai C   Ling Yang Y   Zhou Xifa X   Dong Chunlei C   Luo Judong J   Liu Yongping Y  

PloS one 20131212 12


<h4>Background</h4>Huangqi injection is derived from Astragalus membranaceus root. In China, recent reports of Huangqi injection for the treatment of leucopenia have emerged. However, a systematic review of these reports has not been performed. Thus, we conducted a meta-analysis of clinical controlled trials to assess the clinical value of Huangqi injection in the treatment of leucopenia.<h4>Methods</h4>We searched the Chinese Biomedical Literature Database (CBM), Wanfang Database, China Nationa  ...[more]

Similar Datasets

| S-EPMC5944065 | biostudies-literature
| S-EPMC9081808 | biostudies-literature
| S-EPMC6709080 | biostudies-literature
| S-EPMC5556216 | biostudies-other
| S-EPMC7386972 | biostudies-literature
| S-EPMC4965798 | biostudies-other
| S-EPMC6377994 | biostudies-literature
| S-EPMC7881937 | biostudies-literature
| S-EPMC10589792 | biostudies-literature
| S-EPMC4409435 | biostudies-other